Weekly nab-paclitaxel in combination with cisplatin as neoadjuvant chemotherapy in patients (pts) with locally advanced esophageal squamous cell carcinoma (SCC): Preliminary results of a phase study.

被引：0
|
作者：
Jiang, Youhua
Yun, Fan
Chen, Qixun
Zhou, Xinming
Huang, Zhiyu
Gong, Lei
Yang, Haiyan
Yu, Haifeng
Liu, Jinshi
Chen, Pengcheng
Zhao, Qiang
Mao, Weimin
机构：
[1] Zhejiang Canc Hosp, Dept Thorac Surg, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
[3] Zhejiang Canc Hosp, Key Lab Diag & Treatment Technol Thorac Oncol, Hangzhou, Zhejiang, Peoples R China
[4] Zhejiang Canc Hosp, Canc Res Inst, Hangzhou, Zhejiang, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15062
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A Phase II Trial of Neoadjuvant nab-paclitaxel, Carboplatin, and Gemcitabine (ACaG) in Patients With Locally Advanced Carcinoma of the Bladder
    Grivas, Petros D.
    Hussain, Maha
    Hafez, Khaled
    Daignault-Newton, Stephanie
    Wood, David
    Lee, Cheryl T.
    Weizer, Alon
    Montie, James E.
    Hollenbeck, Brent
    Montgomery, Jeffrey S.
    Alva, Ajjai
    Smith, David C.
    UROLOGY, 2013, 82 (01) : 111 - 117
  • [22] Neoadjuvant chemotherapy with albumin-bound paclitaxel plus cisplatin and capecitabine for locally advanced esophageal squamous cell carcinoma: A prospective phase II trial
    Zhang, Wen
    Li, Yong
    Xue, Liyan
    Qu, Dong
    Jiang, Zhichao
    Gao, Shugeng
    Zhou, Aiping
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [23] Comparison of neoadjuvant nab-paclitaxel plus immunotherapy versus paclitaxel plus immunotherapy for esophageal squamous cell carcinoma
    Yang, Yafan
    Li, Haomiao
    Chen, Xiankai
    Qin, Jianjun
    Li, Yong
    Shen, Yaxing
    Zhang, Ruixiang
    Kang, Xiaozheng
    Wang, Zhen
    Zheng, Qingfeng
    Luo, Peng
    Li, Yin
    He, Jie
    THORACIC CANCER, 2023, 14 (07) : 700 - 708
  • [24] Phase II trial of weekly nab-paclitaxel and carboplatin treatment with or without trastuzumab as nonanthracycline neoadjuvant chemotherapy for locally advanced breast cancer
    Huang, Liang
    Chen, Sheng
    Yao, Ling
    Liu, Guangyu
    Wu, Jiong
    Shao, Zhiming
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2015, 10 : 1969 - 1975
  • [25] A randomized controlled study on perioperative treatment of esophageal squamous cell carcinoma with camrelizumab combined with nab-paclitaxel and cisplatin
    Qi, Yu
    Yang, Yang
    Li, Weihao
    Yue, Songwei
    Ma, Yihui
    Liu, Donglei
    He, Zhanfeng
    Chen, Lidong
    Li, Wencai
    Zhao, Song
    Wang, Congcong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [26] A randomized controlled study on perioperative treatment of esophageal squamous cell carcinoma with camrelizumab combined with nab-paclitaxel and cisplatin
    Qi, Yu
    Yang, Yang
    Li, Weihao
    Yue, Songwei
    Ma, Yihui
    Liu, Donglei
    He, Zhanfeng
    Chen, Lidong
    Li, Wencai
    Li, Linghua
    Zhao, Song
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [27] Tislelizumab combined with nab-paclitaxel and cisplatin as the more effective chemoimmunotherapy strategy in the neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma: A prospective, two-cohort, phase 2 trial
    Wang, Jie
    Li, Bin
    Zhang, Yawei
    Luo, Xiaoyang
    Zhang, Yiliang
    Li, Hang
    Pan, Yunjian
    Shao, Longlong
    Zheng, Shanbo
    Yuan, Chongze
    Li, Yuan
    Zheng, Qiang
    Sun, Si
    Zhao, Weixin
    Sun, Yihua
    INTERNATIONAL JOURNAL OF CANCER, 2025, 156 (07) : 1429 - 1438
  • [28] Camrelizumab combined with albumin paclitaxel and cisplatin as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESCC).
    Lv, Huilai
    Tian, Yang
    Huang, Chao
    Li, Zhenhua
    Tian, Ziqiang
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [29] Efficacy and safety analysis on the combination of camrelizumab with nab-paclitaxel and cisplatin-based chemotherapy in first-line treatment of advanced or metastatic esophageal squamous cell carcinoma.
    Cong, Xiaofeng
    Xu, Zijun
    Liu, Ziling
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (23_SUPPL) : 205 - 205
  • [30] Neoadjuvant Carboplatin/Paclitaxel versus 5-Fluorouracil/Cisplatin in Combination with Radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Comparative Study
    Gao, Xing
    Tsai, Ping-Chung
    Chuang, Kai-Hao
    Pai, Chu-Pin
    Hsu, Po-Kuei
    Li, Shau-Hsuan
    Lu, Hung-, I
    van Lanschot, Joseph Jan-Baptist
    Chao, Yin-Kai
    CANCERS, 2022, 14 (11)
12345